Citation tools
"Radiation Dosimetry Results and Safety Correlations from 90Y-Ibritumomab Tiuxetan Radioimmunotherapy for Relapsed or Refractory Non-Hodgkin’s Lymphoma: Combined Data from 4 Clinical Trials
." Journal of Nuclear Medicine
44.3
(2003):
465-474.
Web. 24 April. 2024.